Connection
Jennifer Diamond to Histone Deacetylases
This is a "connection" page, showing publications Jennifer Diamond has written about Histone Deacetylases.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.185 |
|
|
|
-
Diamond JR, Pitts TM, Ungermannova D, Nasveschuk CG, Zhang G, Phillips AJ, Bagby SM, Pafford J, Yacob BW, Newton TP, Tentler JJ, Gittleman B, Hartman SJ, DeMattei JA, Winkler JD, Wendt MK, Schiemann WP, Eckhardt SG, Liu X, Piscopio AD. Preclinical Development of the Class-I-Selective Histone Deacetylase Inhibitor OKI-179 for the Treatment of Solid Tumors. Mol Cancer Ther. 2022 03 01; 21(3):397-406.
Score: 0.185